Argent Biopharma Limited has released a press release.
AMC Places Second Order of ArtemiC for US$1M
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Malta Production Facility Receives EU-GMP Approval
- Fundraise closed raising up to a total of GBP 2.09m
- CannEpil now available by Named Patient Request in UK
- Funding Commitments Received for GBP 1.8m
- MGC Receive Permission for Psilocybin Research & Development
Later from Argent Biopharma
- Commitments Received for GBP 0.7m
- MGC receives permission for first import of Psilocybin
- MGC Pharma Launches Share Purchase Plan
- Pre-clinical Trial Results on CimetrA
- Share Purchase Plan Closed
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma